SHARPE
Reported results
- Total revenue was $129.5 million in Q2 fiscal 2027, up 10% year-over-year (GAAP).
- Net income was $1.9 million in Q2 fiscal 2027, compared to $0.7 million in the same period in the prior year (GAAP).
- Non-GAAP Adjusted EBITDA was $32.9 million in Q2 fiscal 2027, compared to $22.1 million in the same period in the prior year.
- Free cash flow (non-GAAP) was $13.8 million in Q2 fiscal 2027, compared to $9.6 million in the same period in the prior year.
- Average number of healthcare services clients was 4,744 in the quarter, up 6% year-over-year.
- Total revenue per AHSC was $27,289 in the quarter, up 4% year-over-year.
Guidance
- Fiscal 2027 revenue expected to be in the range of $510 million to $520 million.
- Fiscal 2027 non-GAAP Adjusted EBITDA expected to be in the range of $125 million to $135 million.
- AHSC growth expected to be in the mid-single-digit percentage range for fiscal 2027.
- Total revenue per AHSC expected to grow in the low-single-digit percentage range in fiscal 2027.
Notes
The company implemented a restructuring plan in May 2026 involving approximately 220 position eliminations and expected total restructuring charges of approximately $10 million, substantially all consisting of employee transition costs, severance payments and related benefits. Restructuring charges of $2.8 million were recognized in Q2 fiscal 2027. The AccessOne Acquisition closed on November 12, 2025, and fiscal 2027 revenue outlook assumes approximately $37 million of contribution from AccessOne. As of July 31, 2026, the company had $61 million in borrowings outstanding under a credit facility with Capital One. The calculation of non-GAAP Adjusted EBITDA was updated beginning Q3 fiscal 2026 to include acquisition-related costs; prior periods have not been retroactively adjusted.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-09-02 (8-K, Item 2.02). Read the original filing on sec.gov.